AC Immune S.A. (ACIU)
NASDAQ: ACIU
· Real-Time Price · USD
2.15
0.02 (0.94%)
At close: Aug 15, 2025, 3:59 PM
2.12
-1.17%
After-hours: Aug 15, 2025, 04:45 PM EDT
AC Immune S.A. Cash Flow Statement
Financials in CHF. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -52.08M | -50.92M | -39.86M | -60.51M | -54.58M | -54.23M | -68.24M | -66.61M | -69.42M | -70.75M | -73.28M | -75.68M | -75.11M | -73M | -71.22M | -74.3M | -70.97M |
Depreciation & Amortization | 2.22M | 2.16M | 2.19M | 2.21M | 2.2M | 2.21M | 2.27M | 2.29M | 2.33M | 2.36M | 2.38M | 2.44M | 2.46M | 2.41M | 2.29M | 2.16M | 2.04M |
Stock-Based Compensation | 4.36M | 4.68M | 4.51M | 4.15M | 4.78M | 4.37M | 4.46M | 4.14M | 3.81M | 3.33M | 3.49M | 4.32M | 4.26M | 4.13M | 4.09M | 3.94M | 4.09M |
Other Working Capital | 88.88M | 90.43M | 92.32M | 92.4M | 838K | -360K | -4.75M | -2.64M | -3.66M | -8.31M | -667K | 421K | 2.47M | 6.84M | 2.05M | -308K | -2.14M |
Other Non-Cash Items | 4.4M | 2.03M | 5.47M | 2.48M | -973K | 1.2M | 116K | 389K | 46K | -72K | -1.95M | -6.39M | -5.56M | -6.2M | -4.57M | -27K | -567K |
Deferred Income Tax | n/a | n/a | 506K | 677K | 1.21M | 1.21M | 701K | 530K | n/a | n/a | 4K | 14K | -8K | 130K | 126K | 218K | 368K |
Change in Working Capital | 87.11M | 107.51M | 70.53M | 95.18M | 4.42M | -15.16M | -925K | -2.61M | -4M | -8.43M | -4.63M | 352K | 2.47M | 6.84M | 2.05M | -308K | -2.14M |
Operating Cash Flow | 46M | 65.84M | 43.72M | 44.56M | -42.58M | -60.41M | -61.62M | -61.86M | -67.23M | -73.57M | -73.99M | -74.95M | -71.49M | -65.69M | -67.22M | -68.32M | -67.17M |
Capital Expenditures | -689K | -576K | -652K | -763K | -850K | -801K | -676K | -517K | -899K | -1.24M | -1.92M | -2.29M | -2.38M | -2.63M | -2.78M | -2.54M | -2.28M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -78.01M | -81.46M | -54.27M | -47.36M | 23.39M | 66.45M | 48M | 38M | 68M | 25M | -998K | 4M | -51.03M | -51.03M | -24.99M | -9.99M | 30.04M |
Investing Cash Flow | -78.7M | -105.29M | -78.18M | -71.38M | -716K | 65.64M | 47.32M | 37.48M | 67.1M | 23.76M | -2.92M | 1.71M | -53.41M | -53.66M | -27.78M | -12.53M | 27.75M |
Debt Repayment | -769K | -683K | -651K | -618K | -580K | -548K | -552K | -556K | -563K | -569K | 22.89M | 22.89M | 22.92M | 22.95M | -478K | -442K | -433K |
Common Stock Repurchased | -5K | n/a | n/a | n/a | n/a | -6K | -6K | -6K | -6K | n/a | n/a | n/a | n/a | -12K | -112K | -112K | -111K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -12K | -12K | -12K | -12K | n/a | n/a | n/a |
Other Financial Acitivies | -25K | -548K | -547K | -547K | 1.53M | 2.05M | 2.04M | 2.04M | -2K | -777K | 307K | 306K | 438K | 1.09M | -339K | -339K | -475K |
Financial Cash Flow | -690K | -1.12M | 40.1M | 40.73M | 42.7M | 43.25M | 2.07M | 1.48M | -571K | -1.35M | 27.54M | 32.01M | 32.12M | 40.75M | 11.55M | 7.37M | 7.28M |
Net Cash Flow | -37.05M | -42.22M | 490K | 11.56M | -425K | 46.91M | -12.58M | -23.14M | -401K | -50.63M | -49.08M | -40.99M | -93.26M | -78.68M | -82.98M | -73.33M | -31.77M |
Free Cash Flow | 45.31M | 65.27M | 43.06M | 43.8M | -43.43M | -61.21M | -62.3M | -62.38M | -68.13M | -74.81M | -75.91M | -77.25M | -73.88M | -68.32M | -70.01M | -70.86M | -69.45M |